The round was led by Hanaco Ventures, alongside Dexcel Pharma, and Peregrine Ventures, bringing the total funding to over $50 million. Funds to be used to support company’s pivotal trials for stroke survivors in U.S. hospitals
E-Mail
IMAGE: A research participant wearing the BrainQ System, an AI-powered device that delivers electromagnetic stimulation to the upper extremity of individuals with impaired motor abilities. view more
Credit: BrainQ Technologies
East Hanover, NJ. January 14, 2021. Ghaith Androwis, PhD, and Steven Kirshblum, MD, received a grant from BrainQ Technologies to study a potential treatment for arm and hand dysfunction in individuals with chronic spinal cord injury. The study is titled, The safety and effectiveness of the use of a brain-computer interface-based electromagnetic field treatment in the management of patients with chronic spinal cord injury: A pilot study.
Dr. Androwis is a research scientist in the Center for Mobility and Rehabilitation Engineering Research at Kessler Foundation. Dr. Kirshblum is senior medical officer and director of the Spinal Cord Injury Program for Kessler Institute for Rehabilitation, chief academic officer for the Select Medical R